Researchers announced Tuesday the beginning of a FDA-approved clinical trial that uses umbilical cord blood stem cells to ‘cure’ autism.
Dr. Michael Chez, director of pediatric neurology at Sutter
Neuroscience Institute in Sacramento, Calif., said he and his colleagues
have been processing the trial for more than a year now, and they have
high hopes it will succeed.
Tuesday, August 21, 2012
FDA-Approved Clinical Trial to Cure Autism Begins
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment